Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jorge Sánchez-Villegas"'
Autor:
Guillermo Romero-Molina, María Asunción Navarro-Puerto, Marta Pérez-Quintana, María J Pérez-Quintana, Rocío Gómez-Herreros, María L. Martín-Ponce, José del Valle-Villagrán, José L Marenco-de la Fuente, Lucía Serrano-Rodríguez, Isabel Melguizo-Moya, Isabel Manoja-Bustos, Alejandra de Miguel-Albarreal, José A. García-García, María J Velasco-Romero, Isabel Cebrián-González, José A Mira-Escarti, Jorge Marín-Martín, Jorge Sánchez-Villegas, Consuelo Ramos-Giráldez, Daniel León-Martí, Francisco Mula-Falcón, Pilar Fernández-Pérez, Salvador Vergara-López
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 17
Journal of Clinical Medicine, Vol 10, Iss 4019, p 4019 (2021)
Volume 10
Issue 17
Journal of Clinical Medicine, Vol 10, Iss 4019, p 4019 (2021)
Background: Immunomodulatory drugs have been used in patients with severe COVID-19. The objective of this study was to evaluate the effects of two different strategies, based either on an interleukin-1 inhibitor, anakinra, or on a JAK inhibitor, such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3efbb14186d4de1019175a66183ac4a5
Autor:
Pere Domingo, Onofre Martinez-Madrid, Jorge Sánchez-Villegas, Miguel Genebat, José Hernández-Quero, José F. Lluch, José M. Guardiola, Ezequiel Ruiz-Mateos, Jorge Marín, María A. Martínez-Pérez, Francisco García de la Llana, Hortensia Álvarez, Francisco Vera, Ana Mariño, Manuel Leal, Lorena Martínez
Publikováno v:
Antiviral Research. 104:59-61
Efficacy and tolerability of telaprevir, pegylated interferon and ribavirin combination was assessed in 32 cirrhotic genotype 1 hepatitis C (HCV)–HIV coinfected patients. Undetectability of HCV-RNA was observed in 23/32 (71.9%) patients after 24 we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6ddef28f30f5a6e990c9997864702db
https://doi.org/10.1016/j.antiviral.2014.01.019
https://doi.org/10.1016/j.antiviral.2014.01.019